Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02061215 · ClinicalTrials.gov registry record
Study of CMV in Kidney Transplant Recipients
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02061215: Clinical Trial study, sponsored by University of Nebraska.
NCT02061215 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02061215 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Using novel CYTOF technology to measure a wide array of innate and adaptive cell proportions and cytokine levels, we plan a pilot study in old (\>/=60 years) and young (20-40 years) renal transplant recipients who are cytomegalovirus (CMV) seropositive (regardless of donor serology). Viral load measurements will be performed at baseline prior to transplant (within 1 week),and then at 3, 7 and 10 months after transplant. It is expected that the patient will receive anti-CMV prophylaxis until 6 months post-transplant, so the latter two time points will reflect responses after "release" from antiviral suppression. Each patient will serve as their own control, with comparisons made between measurements at baseline and then at each timepoint. In addition, clinical data will be collected at the time points indicated, particularly renal function and the presence/absence of acute rejection.
Primary Outcome
CMV viral loads in younger (age 20-40) seropositive kidney transplant recipients before renal transplant, during treatment with anti-viral therapy, and after release from therapy
Interventions
- OTHER CMV viral load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07-14 |
Why NCT02061215 stopped before completion
NCT02061215 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CMV viral load is the first listed.
NCT02061215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02061215 about?
NCT02061215 is a clinical study titled "Study of CMV in Kidney Transplant Recipients". Using novel CYTOF technology to measure a wide array of innate and adaptive cell proportions and cytokine levels, we plan a pilot study in old (\>/=60 years) and young (20-40 years) renal transplant recipients who are cytomegalovirus (CMV) seropositive (regardless of donor serology). Viral load meas...
What is the current status of trial NCT02061215?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2014-04. Estimated completion is 2015-07-14.
What interventions are being tested in trial NCT02061215?
The interventions under investigation include: CMV viral load (OTHER).
Who is sponsoring clinical trial NCT02061215?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia